Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H LUND

Showing results (691-700 of 826) with videos related to

Pageof 83
Sort By:
Communications Biology|June 19, 2021
Predicting the probability of death using proteomicsThjodbjorg Eiriksdottir, Steinthor Ardal, Benedikt A Jonsson, et al.
ESC Heart Failure|April 9, 2026
CONFIDENT-HFpEF: A Machine Learning-Based Risk Stratification for Mortality and Hospitalization Using Multimodal Real-World DataMarat Fudim, Vanessa Van Empel, Tobias Zehnder, et al.
European Journal of Heart Failure|June 15, 2022
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of CardiologyPeter Seferović, Dimitrios Farmakis, Antoni Bayes-Genis, et al.
European Journal of Heart Failure|September 11, 2025
Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomesBenedikt N Beer, Lina Benson, Christian Basile, et al.
ESC Heart Failure|April 10, 2026
An integrated Biobank in the Swedish Heart Failure Registry - clinomics, proteomics, transcriptomics and genomicsCamilla Hage, Therese Andersson, Christina Christersson, et al.
European Journal of Heart Failure|May 28, 2019
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real worldChris J Kapelios, Mitja Lainscak, Gianluigi Savarese, et al.
Science Advances|January 17, 2025
Pellino 3 E3 ligase promotes starvation-induced autophagy to prevent hepatic steatosisSrinivasa P Kolapalli, Carsten J Beese, Steven E Reid, et al.
ESC Heart Failure|April 7, 2022
Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fractionGianluigi Savarese, Alicia Uijl, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|February 24, 2023
Personalized care of patients with heart failure: are we ready for a REWOLUTION? Insights from two international surveys on healthcare professionals' needs and patients' perceptionsEwa A Jankowska, Peter P Liu, Martin R Cowie, et al.
American Journal of Human Genetics|February 11, 1999
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiencyB S Andresen, S Olpin, B J Poorthuis, et al.
Pageof 83

Showing results (691-700 of 826) with videos related to

Sort By:
Pageof 83
Communications Biology|June 19, 2021
Predicting the probability of death using proteomicsThjodbjorg Eiriksdottir, Steinthor Ardal, Benedikt A Jonsson, et al.
ESC Heart Failure|April 9, 2026
CONFIDENT-HFpEF: A Machine Learning-Based Risk Stratification for Mortality and Hospitalization Using Multimodal Real-World DataMarat Fudim, Vanessa Van Empel, Tobias Zehnder, et al.
European Journal of Heart Failure|June 15, 2022
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of CardiologyPeter Seferović, Dimitrios Farmakis, Antoni Bayes-Genis, et al.
European Journal of Heart Failure|September 11, 2025
Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomesBenedikt N Beer, Lina Benson, Christian Basile, et al.
ESC Heart Failure|April 10, 2026
An integrated Biobank in the Swedish Heart Failure Registry - clinomics, proteomics, transcriptomics and genomicsCamilla Hage, Therese Andersson, Christina Christersson, et al.
European Journal of Heart Failure|May 28, 2019
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real worldChris J Kapelios, Mitja Lainscak, Gianluigi Savarese, et al.
Science Advances|January 17, 2025
Pellino 3 E3 ligase promotes starvation-induced autophagy to prevent hepatic steatosisSrinivasa P Kolapalli, Carsten J Beese, Steven E Reid, et al.
ESC Heart Failure|April 7, 2022
Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fractionGianluigi Savarese, Alicia Uijl, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|February 24, 2023
Personalized care of patients with heart failure: are we ready for a REWOLUTION? Insights from two international surveys on healthcare professionals' needs and patients' perceptionsEwa A Jankowska, Peter P Liu, Martin R Cowie, et al.
American Journal of Human Genetics|February 11, 1999
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiencyB S Andresen, S Olpin, B J Poorthuis, et al.
Pageof 83